Table 2 Mean annual costs per patient for highest and lowest cost scenarios across cohorts
From: The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis
Non-asthma (n = 2411) | Mild/Moderate asthma (n = 3975) | Severe asthma (n = 808) | ||||
|---|---|---|---|---|---|---|
Low | High | Low | High | Low | High | |
Clinical activitya | £ 350 ± 546 | £ 1111 ± 2372 | £ 491 ± 630 | £ 1579 ± 2902 | £ 911 ± 907 | £ 2799 ± 3705 |
Prescription drugsa | £ 210 ± 790 | £ 212 ± 700 | £ 487 ± 957 | £ 493 ± 947 | £ 1692 ± 2369 | £ 1734 ± 2346 |
Total cost | £ 560 | £ 1324 | £ 978 | £ 2072 | £ 2603 | £ 4533 |